CompletedPhase 1/2

Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles

Egypt30 participantsStarted 2022-12-21

Plain-language summary

In this study, The investigators aims to evaluate the efficacy and safety of topical hyaluronic acid nanoparticles as a novel nanodermatological tool in periocular rejuvenation as a replacement approach of invasive dermal filler injections.

Who can participate

Age range21 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Is a healthy male or female between 21 and 65 years old
✓. Is voluntarily willing to consent to participate in the study
✓. Is willing to comply with all requirements of the study including being photographed, follow post treatment care instructions, to attend all treatment, and follow up visits
✓. Willingness to waive rights to use of still photos of themselves for research, marketing, or promotional reasons, including on the internet and on social media outlets.
✓. Willingness to refrain from other surgical, laser, or injectable treatments in the periorbital region during the entire duration of the study.
✓. Ability to provide informed consent.

What they're measuring

The efficacy of topical hyaluronic acid nanoparticles in treatment of tear trough

Timeframe: 1 month

Assessment of improvement of tear trough by topical hyaluronic acid nanoparticles

Timeframe: up to 4 weeks

Patient satisfaction of topical hyaluronic acid nanoparticles in treatment of tear trough

Timeframe: 1 month

Incidence of side effects of topical hyaluronic acid nanoparticles around eyes

Timeframe: up to 4 weeks

Trial details

NCT IDNCT05742399

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-15

View on ClinicalTrials.gov More Tear Trough Eyelid Deformity trials